Main > ONCOLOGY (**) > Pancreas Cancer>MET>MSI-H*** > Treatment > Co: USA. M. PembrolizuMAb

---

Co: USA. M. PembrolizuMAb's subsections
(*) USA Approval Date: 2017. 05.23
Company
Mismatch Repair Deficient
MSI-H: MicroSatellite Instability->
Press Release Web-Site (Company)
TradeMark
TradeMark Web-Site
UpDate: 2017. 05.25

Co: USA. M. PembrolizuMAb's products
This section has no products